Skip to content
healthcare.dev

Avastin

NDC 50242-061, bevacizumab, injection, solution, from Genentech, Inc..

Product NDC
50242-061
Status
Listed
Labeler
Genentech, Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125085
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50242-061 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BEVACIZUMAB400 mg/16mL

Pharmacologic classes

Vascular Endothelial Growth Factor Inhibitor [EPC]; Vascular Endothelial Growth Factor Inhibitors [MoA]; Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
50242-061-01502420061011 VIAL, SINGLE-USE in 1 CARTON (50242-061-01) / 16 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/939b5d1f-9fb2-4499-80ef-0607aa6b114e
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=50242-061

Use it

Look up 50242-061 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50242-061 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50242-061. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.